BOSTON OMAHA CORP-CL A (BOC) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:BOC - US1010441053 - Common Stock
12.28 USD
+0.04 (+0.33%)
ChartMill assigns a Buy % Consensus number of 45% to BOC. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 14.28. This target is 16.29% above the current price.
- BOC was analyzed by 8 analysts. The buy percentage consensus is at 45. So analysts seem to be rather negative about BOC.
- In the last month the buy percentage fell by 32 points. So the trust of analysts is decreasing.
- BOC was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-04-09 | TD Cowen | Maintains | Buy -> Buy |
| 2024-09-19 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2024-08-21 | TD Cowen | Maintains | Buy -> Buy |
| 2024-05-20 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-04-02 | TD Cowen | Maintains | Buy -> Buy |
| 2023-08-29 | TD Cowen | Maintains | Outperform -> Outperform |
| 2023-08-25 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2023-05-24 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2023-05-18 | TD Cowen | Maintains | Outperform -> Outperform |
| 2023-03-31 | TD Cowen | Maintains | Outperform |
| 2023-03-29 | Wells Fargo | Maintains | Overweight |
| 2022-11-01 | Wells Fargo | Maintains | Overweight |
| 2022-05-25 | Wells Fargo | Maintains | Overweight |
| 2022-04-12 | Wells Fargo | Maintains | Overweight |
BOSTON OMAHA CORP-CL A / BOC FAQ
What is the average price target for BOSTON OMAHA CORP-CL A (BOC) stock?
8 analysts have analysed BOC and the average price target is 14.28 USD. This implies a price increase of 16.29% is expected in the next year compared to the current price of 12.28.
What is the consensus rating for BOC stock?
The consensus rating for BOSTON OMAHA CORP-CL A (BOC) is 45 / 100 . This indicates that analysts generally have a neutral outlook on the stock.